BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6208054)

  • 21. Effect of endogenous digoxin-like factor and digoxin antibody on myocardial Na+, K(+)-pump activity and ventricular arrhythmias in acute myocardial ischaemia in rats.
    Bagrov AY; Fedorova OV; Roukoyatkina NI; Zhabko EP
    Cardiovasc Res; 1993 Jun; 27(6):1045-50. PubMed ID: 8221762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Na+/K+-ATPase inhibitors in bovine plasma as fatty acids and hydrocarbons.
    Tal DM; Yanuck MD; van Hall G; Karlish SJ
    Biochim Biophys Acta; 1989 Oct; 985(1):55-9. PubMed ID: 2551389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dehydroepiandrosterone sulfate as a digitalis like factor in plasma of healthy human adults.
    Vasdev S; Longerich L; Johnson E; Brent D; Gault MH
    Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):387-99. PubMed ID: 2997888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observations on a low molecular weight natriuretic and Na-K-ATPase inhibitory material in urine.
    Clarkson EM; de Wardener HE
    Clin Exp Hypertens A; 1985; 7(5-6):673-83. PubMed ID: 2990768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitive assay and kinetic property of urinary inhibitor of Na+, K+-ATPase in sodium-loaded patients with essential hypertension.
    Masugi F; Ogihara T; Hasegawa T; Imai N; Nagano M; Tabuchi Y; Kumahara Y
    Jpn Circ J; 1985 Sep; 49(9):980-3. PubMed ID: 2999460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Higher plasma Na+,K+-ATPase inhibitory activity in essential hypertensive patients.
    Vasdev S; Fernandez PG; Longerich L; Gault H
    Can J Cardiol; 1989; 5(5):249-54. PubMed ID: 2547501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Na-K-ATPase inhibitor dissociated from hypertension-associated plasma protein.
    Weiler EW; Khalil-Manesh F; Gonick HC; Prins BA; Purdy RE; Sensharma DK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):364-73. PubMed ID: 10232496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of linoleic and oleic acids as endogenous Na+,K+-ATPase inhibitors from acute volume-expanded hog plasma.
    Tamura M; Kuwano H; Kinoshita T; Inagami T
    J Biol Chem; 1985 Aug; 260(17):9672-7. PubMed ID: 2991258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of two cardiac glycosides as Na(+)-pump inhibitors in rat urine and diet.
    Tamura M; Harris TM; Phillips D; Blair IA; Wang YF; Hellerqvist CG; Lam SK; Inagami T
    J Biol Chem; 1994 Apr; 269(16):11972-9. PubMed ID: 8163500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical characterization of a digitalis-like substance in human urine, partially purified by high pressure liquid chromatography.
    Takeda R; Morise T; Ikeda M; Okamoto S
    Cardiology; 1989; 76(6):442-9. PubMed ID: 2558793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma endogenous digitalis-like factors in healthy individuals and in dialysis-dependent and kidney transplant patients.
    Vasdev S; Johnson E; Longerich L; Prabhakaran VM; Gault MH
    Clin Nephrol; 1987 Apr; 27(4):169-74. PubMed ID: 3034459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Affinity chromatographic study of the changes in the endogenous Na+-K+-ATPase inhibitor during sodium loading in man].
    Cloix JF; Henning G; Crabos M; Delva P; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1251-5. PubMed ID: 6098236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous inhibition of red blood cell Na,K-ATPase in essential and pregnancy-induced hypertension.
    Ringel R; Pinkas G; Hamlyn J; Mullins L; Hamilton B
    Clin Exp Hypertens A; 1989; 11(4):587-601. PubMed ID: 2551544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digoxin-binding antibodies reverse the effect of endogenous digitalis-like compounds on Na,K-ATPase in erythrocytes.
    Balzan S; Montali U; Biver P; Ghione S
    J Hypertens Suppl; 1991 Dec; 9(6):S304-5. PubMed ID: 1668002
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of photochemical degradation of digoxin by Na,K-ATPase assay.
    Vasić V; Cernigoj U; Krinulović K; Joksić G; Franko M
    J Pharm Biomed Anal; 2006 Feb; 40(2):404-9. PubMed ID: 16384681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous inhibitors of the Na+, K(+)-pump and platelet Ca2+ handling in hypertension.
    Devynck MA; David-Dufilho M; Astarie C; Mazeaud M; Pernollet MG; Le Quan Sang KH
    Physiol Bohemoslov; 1990; 39(1):71-8. PubMed ID: 2165268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of cardiodigin, endogenous inhibitor of Na+,K+-ATPase, with antidigoxin and antidigitoxin antibodies.
    Fagoo M; Godfraind T
    Biochem Biophys Res Commun; 1985 Jun; 129(2):553-9. PubMed ID: 2990458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipids as endogenous Na,K-ATPase inhibitors in plasma of healthy individuals and in dialysis dependent patients.
    Vasdev SC; Longerich L; Prabhakaran VM; Triggle CR; Gault MH
    Clin Biochem; 1989 Aug; 22(4):313-9. PubMed ID: 2550162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extraction and characterization of a cytochemically assayable Na+/K+-ATPase inhibitor/glucose-6-phosphate dehydrogenase stimulator in the hypothalamus and plasma of man and the rat.
    Millett JA; Holland SM; Alaghband-Zadeh J; de Wardener HE
    J Endocrinol; 1987 Feb; 112(2):299-303. PubMed ID: 3029264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (Na+ + K+) ATPase inhibitors and intracellular electrolytes in essential hypertension.
    Iwaoka T; Nugent CA; Umeda T; Sato T
    Jpn Heart J; 1987 Sep; 28(5):695-705. PubMed ID: 2828706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.